Welch & Forbes LLC Abbott Laboratories Transaction History

Welch & Forbes LLC

$7.73 Billion
Q3 2024

A detailed history of Welch & Forbes LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Welch & Forbes LLC holds 639,109 shares of ABT stock, worth $74.7 Million. This represents 0.94% of its overall portfolio holdings.

Number of Shares

639,109

Previous 645,512 0.99%

Holding current value

$74.7 Million

Previous $67.1 Million 8.63%

% of portfolio

0.94%

Previous 0.91%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$100.07 - $118.13 $640,748 - $756,386	-6,403 Reduced 0.99%	639,109 $72.9 Million
Q2 2024 Aug 01, 2024	SELL	$100.73 - $112.44 $71,820 - $80,169	-713 Reduced 0.11%	645,512 $67.1 Million
Q1 2024 May 02, 2024	BUY	$109.52 - $120.96 $828,628 - $915,183	7,566 Added 1.18%	646,225 $73.4 Million
Q4 2023 Feb 06, 2024	SELL	$90.19 - $110.4 $339,926 - $416,097	-3,769 Reduced 0.59%	638,659 $70.3 Million
Q3 2023 Nov 02, 2023	SELL	$95.53 - $114.62 $392,246 - $470,629	-4,106 Reduced 0.64%	642,428 $62.2 Million
Q2 2023 Jul 28, 2023	BUY	$100.78 - $112.29 $40,916 - $45,589	406 Added 0.06%	646,534 $70.5 Million
Q1 2023 Apr 14, 2023	SELL	$96.86 - $114.01 $110,614 - $130,199	-1,142 Reduced 0.18%	646,128 $65.4 Million
Q4 2022 Feb 02, 2023	SELL	$95.06 - $111.52 $181,849 - $213,337	-1,913 Reduced 0.29%	647,270 $71.1 Million
Q3 2022 Oct 28, 2022	BUY	$96.76 - $112.03 $347,948 - $402,859	3,596 Added 0.56%	649,183 $62.8 Million
Q2 2022 Jul 22, 2022	SELL	$102.07 - $123.37 $217,102 - $262,407	-2,127 Reduced 0.33%	645,587 $70.1 Million
Q1 2022 Apr 25, 2022	BUY	$114.02 - $139.04 $166,925 - $203,554	1,464 Added 0.23%	647,714 $76.7 Million
Q4 2021 Jan 19, 2022	SELL	$115.53 - $141.46 $596,134 - $729,933	-5,160 Reduced 0.79%	646,250 $91 Million
Q3 2021 Oct 13, 2021	BUY	$116.66 - $129.06 $28,115 - $31,103	241 Added 0.04%	651,410 $77 Million
Q2 2021 Jul 22, 2021	BUY	$105.79 - $124.53 $242,259 - $285,173	2,290 Added 0.35%	651,169 $75.5 Million
Q1 2021 Apr 14, 2021	BUY	$108.84 - $128.23 $538,758 - $634,738	4,950 Added 0.77%	648,879 $77.8 Million
Q4 2020 Jan 20, 2021	SELL	$105.0 - $114.42 $995,400 - $1.08 Million	-9,480 Reduced 1.45%	643,929 $70.5 Million
Q3 2020 Oct 23, 2020	BUY	$91.64 - $111.29 $980,914 - $1.19 Million	10,704 Added 1.67%	653,409 $71.1 Million
Q2 2020 Jul 15, 2020	SELL	$76.57 - $98.0 $585,377 - $749,210	-7,645 Reduced 1.18%	642,705 $58.8 Million
Q1 2020 Apr 17, 2020	BUY	$62.82 - $91.86 $354,179 - $517,906	5,638 Added 0.87%	650,350 $51.3 Million
Q4 2019 Jan 17, 2020	BUY	$78.51 - $87.4 $1.06 Million - $1.18 Million	13,447 Added 2.13%	644,712 $56 Million
Q3 2019 Oct 11, 2019	BUY	$81.84 - $88.74 $492,922 - $534,481	6,023 Added 0.96%	631,265 $52.8 Million
Q2 2019 Jul 12, 2019	SELL	$72.88 - $85.0 $677,419 - $790,075	-9,295 Reduced 1.46%	625,242 $52.6 Million
Q1 2019 Apr 29, 2019	BUY	$66.22 - $80.06 $146,279 - $176,852	2,209 Added 0.35%	634,537 $50.7 Million
Q4 2018 Feb 05, 2019	BUY	$65.56 - $74.27 $269,058 - $304,804	4,104 Added 0.65%	632,328 $45.7 Million
Q3 2018 Oct 17, 2018	BUY	$60.81 - $73.36 $131,167 - $158,237	2,157 Added 0.34%	628,224 $46.1 Million
Q2 2018 Jul 16, 2018	BUY	$57.57 - $63.54 $119,572 - $131,972	2,077 Added 0.33%	626,067 $38.2 Million
Q1 2018 Apr 12, 2018	BUY	$56.27 - $63.62 $35.1 Million - $39.7 Million	623,990 New	623,990 $37.4 Million
Q4 2017 Jan 26, 2018	SELL	$53.68 - $57.47 $33.6 Million - $36 Million	-625,928 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $30.1 Million - $33.6 Million	625,928	625,928 $33.4 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Welch & Forbes LLC, based on Form 13F filings with the SEC.

News

Stay updated on Welch & Forbes LLC with notifications on news.

Account